US OKs Neoprobe's intra-operative blood flow measuring technology:
This article was originally published in Clinica
Executive Summary
Neoprobe has received US FDA 510(k) clearance to market its ultrasound-based system for the intra-operative measurement of blood flow. The Quantix/OR consists of an angle-independent ultrasound probe that obtains signals directly from the blood vessel and measures blood flow in the vessel regardless of vessel size. Dublin, Ohio-based Neoprobe said it would start clinical evaluations of the device at leading US institutions, with a view to supporting its efforts to develop a US market for the product through one or more established national sales representative organisations.